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Abstract Sphingoid long chain base phosphates (LCBPs) reg-
ulate cell proliferation, survival and motility in mammals. To
learn more about LCBPs in Saccharomyces cerevisiae, we de-
termined the cellular location of Lcb4p, the major enzyme cata-
lyzing LCBP synthesis. By indirect immuno£uorescence micros-
copy and subcellular fractionation, Lcb4p localizes to the trans-
Golgi network and late endosomes and cycles between these
compartments. Lcb4p faces the cytosol and is probably bound
to membranes by protein^protein interactions. These results in-
dicate that LCBs made in the endoplasmic reticulum must trans-
it to the Golgi to be converted into LCBPs, which must then
return to the endoplasmic reticulum to be degraded.
) 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Phosphorylated species of sphingoid long chain bases
(LCBPs) have been identi¢ed in all eukaryotes examined.
The major LCBP in mammals is sphingosine-1-phosphate,
an important signal for regulating multiple processes includ-
ing proliferation, survival, motility, cytoskeletal mechanics
and di¡erentiation (reviewed in [1,2]). Sphingosine-1-phos-
phate formation in humans is catalyzed by two related sphin-
gosine kinases, SPHK1 and SPHK2 [3], that are members of a
family of enzymes found in all eukaryotes. Conservation of
LCBPs and the enzymes that catalyze their formation suggest
that LCBPs perform important, perhaps conserved, functions
in all organisms. However, studies using Saccharomyces cere-
visiae have yet to identify speci¢c functions for LCBPs and
mutant strains that lack LCBPs display near-normal behavior
[4]. To gain insight into the function of LCBPs we sought to
determine their site or sites of synthesis by determining the
cellular location of Lcb4p, the major long chain base (LCB)
kinase in yeast.
S. cerevisiae cells have two kinases, Lcb4p and Lcb5p [4],
that phosphorylate dihydrosphingosine (DHS) and phyto-
sphingosine (PHS) to yield DHS-P and PHS-P. Lcb4p ac-
counts for 97% of total cellular LCB kinase activity and
Lcb5p accounts for the remainder. Since DHS-P and PHS-P
are degraded by two phosphatases, Lcb3p and Ysr3p, and by
the Dpl1 lyase, all of which are located in the endoplasmic
reticulum (ER) [5,6], it seemed likely that Lcb4p and Lcb5p
would also be in the ER. However, we ¢nd that most of the
Lcb4p is in the Golgi apparatus and in late endosomes.
2. Materials and methods
2.1. Strains and culture conditions
The strains used in this study are parental strain RCD224 (MATa
leu2-3, 112 ura3-52 trp1 his4 rme1 [7]) and derivatives of it including
RCD220 (MATa) and RCD221 (MATK) which carry lcb4-v1: :KAN
lcb5-v1: :KAN. VPS27 was deleted in strain BY4741 (Sacchoromyces
genome deletion project Stanford University: MATa his-3v1 leu2v0
met 15v0 ura3v0 vps27: :KAN). This strain was crossed to RCD221 to
yield RCD388 (MATa leu2v ura3v rme1 met15v his3 lcb4-v1: :KAN
lcb5-v1: :KAN vps27: :KAN). Yeasts were grown in yeast extract,
peptone, dextrose (YPD) [8] or de¢ned medium (SD) containing
0.134% yeast nitrogen base (Difco), 2% glucose and the supplements
decribed previously [8]. SSuc is de¢ned medium with 2% sucrose in
place of glucose and S-Ura is medium that lacks uracil.
2.2. Plasmids
pLCB4-26 contains 462 bases of the LCB4 promoter plus the cod-
ing region fused in-frame to three hemagglutinin (HA) epitopes, fol-
lowed by the CYC1 terminator. The plasmid was constructed by in-
serting a polymerase chain reaction (PCR) fragment into the BamH1
and Pstl sites of pPAD82 (CEN4 URA3, [9]). pLCB4-27 has the LCB4
coding region cloned downstream of the GAL1 promoter (between the
XbaI and HindIII sites) carried in YCplac33GAL (CEN4 URA3,
GAL1 promoter cloned into YCplac33, [10]). The 3P end of the coding
region is tagged with codons for three HA epitopes in the same way as
in pLCB4-26.
2.3. Immunoblotting and immuno£uorescence microscopy
Cell-free yeast extracts [4] were subjected to SDS^PAGE and West-
ern blotting using polyvinylidene £uoride membranes. Rabbit poly-
clonal antibodies were made against a peptide (AKSKKELKVH-
FLENKDKNK) representing residues 423^441 of Lcb4p, were
a⁄nity-puri¢ed using the peptide as a ligand, and used at a 1/1000
dilution for an overnight incubation. Secondary antibody was goat
anti-rabbit-IgG-alkaline phosphatase (Gibco-BRL, #13869-011) di-
luted 1/1000 and incubated 4 h with immunoblots. The phosphatase
substrate was ECF (Amersham Pharmacia Biotech #RPN5785) and
the £uorescent signal was quanti¢ed by using a Molecular Dynamics
Storm imaging system. Antibodies against Vph1p, 3-phospho-glycer-
ate kinase, Dpm1p and a mitochondrial porin were from Molecular
Probes.
Indirect immuno£uorescence staining of formaldehyde-¢xed cells
[11] used rat anti-HA antibody (3F10, Boehringer), rabbit anti-
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Tlg1p (Dr. S. Munro), rabbit anti-Pep12p (Molecular Probes), rabbit
anti-Sec7p (Dr. R. Schekman) and rabbit anti-Pma1p (Dr. R. Serra-
no). Secondary antibodies were FITC-goat anti-rat IgG (Sigma) or
Cy3-goat anti-rabbit IgG (Amersham Pharmacia Biotech).
2.4. Subcellular fractionation and enzyme assay
Yeast cells were broken [4] and the lysate was fractionated at 4‡C
by sequentially centrifuging at 500Ug for 5 min (P0.5 and S0.5),
13 000Ug for 10 min (P13 and S13) and 100 000Ug for 60 min
(P100 and S100) [12]. For the experiments presented in Fig. 3, cells
grown to an A600 nm of 0.7 were converted to spheroplasts, gently
lysed [12] and fractionated at 4‡C by using the same sequential cen-
trifugation protocol as used for the crude subcellular fractionation
procedure. The P100 was resuspended in 2 ml of hypo-osmotic bu¡er
(50 mM Tris^HCl, pH 7.5, 200 mM sorbitol, 1 mM EDTA plus
protease inhibitors and loaded on top of a 22^60% (w/w) sucrose
step gradient. Gradients were centrifuged at 4‡C in a Beckman
SW40Ti rotor at 170 000Ug for 18 h and 16 fractions were collected
starting at the top.
Membrane association of Lcb4-3HA was measured by using the
P100 membrane fraction suspended in bu¡er (50 mM Tris, pH 7.5,
5 mM dithiothreitol (DTT), 1 mM phenylmethylsulphonyl £uoride
(PMSF), 1 Wg/ml each of leupeptin, pepstatin and aprotinin). Samples
of the P100 were adjusted to ¢nal concentrations of 0.5 M potassium
acetate (pH 4.5), 1 M sodium chloride, 0.1 M sodium carbonate (pH
11) and 5 M urea. Samples were incubated on ice for 30 min, vortexed
at high speed for six cycles (30 s vortexing and 1 min on ice), centri-
fuged at 100 000Ug for 45 min at 4‡C and immunoblotted.
For detergent treatment, the P100 fraction was incubated with 0.5%
or 1.0% Triton X-100 for 120 min on ice and either sonicated 30 s
with a microprobe (Heat System Ultrasonic) or not sonicated fol-
lowed by centrifugation at 100 000Ug for 60 min. The supernatant
and pellet fractions were immunoblotted.
Lcb4p and Lcb5p kinase activity was measured as described pre-
viously [4]. All protein concentrations were quanti¢ed by using a Bio-
Rad DC kit with bovine serum albumin as a standard.
2.5. Trypsin sensitivity
RCD220 cells, transformed with pLCB4-26 or pWP1055 [13], were
grown in SD to an A600 nm of 0.7. Equal amounts of cells (120 A600 nm
units) were mixed, converted to spheroplasts [12] and centrifuged to
yield a P100 fraction which was suspended in bu¡er (50 mM HEPES,
pH 7.5, 5 mM DTT). Ice-cold P100 was treated with trypsin (0.1 mg/
ml) in the presence or absence of 0.5% Triton X-100 for up to 30 min.
Reactions were stopped by using trypsin inhibitor type I-S and 1 mM
PMSF.
3. Results
3.1. Overproduction of epitope-tagged Lcb4p
About two-thirds of the Lcb4p kinase activity was found to
be on membranes [4], an unexpected result, since the protein
has no predicted transmembrane domains nor sites for cova-
lent lipid attachment. For localization studies, rabbit poly-
clonal antibodies were prepared against Lcb4p. Parental
RCD224 but not lcb4v lcb5v cells (strain RCD220) showed
a band of 75 kDa, the predicted size of Lcb4p, on an immu-
noblot (Fig. 1A, compare lanes 1 and 2). Thus, the antibody
detects Lcb4p; however, speci¢city is poor and the antibodies
react with other proteins (data not shown).
To improve the speci¢city of detecting Lcb4p, three hemag-
glutin (HA) epitopes were added to its C-terminus and the
tagged gene was expressed on a single-copy vector (pLCB4-
26) in lcb4v lcb5v (RCD220) cells under the control of its own
promoter. Lcb4p-3HA was detected with anti-Lcb4 antibody
as a slightly larger protein of about the same concentration as
untagged Lcb4p (Fig. 1, compare lanes 2 and 3). Anti-HA
antibody was used in most experiments because detection of
Lcb4p-3HA was more speci¢c and sensitive (data not shown).
For some experiments Lcb4p had to be overproduced about
two-fold to be detected. Overproduction was achieved by
driving transcription of LCB4-3HA with the galactose-induc-
ible GAL1 promoter (pLCB4-27). Cells carrying pLCB4-27
had no detectable Lcb4p-3HA protein when grown in medium
containing glucose (Fig. 1, lane 4). Changing the carbon
source from glucose to galactose and incubating for 6 or
24 h increased the level of Lcb4p to two- and 13-fold, respec-
tively, above the wild-type level (Fig. 1A, compare lanes 5 and
6 to lane 2). Alternatively, ra⁄nose was used as the carbon
source and a 2 h incubation with galactose induced Lcb4p-
3HA to about the wild-type level (Fig. 2C).
Neither the presence of the epitope tag nor two-fold over-
production changed the subcellular distribution of Lcb4p-
3HA compared to wild-type Lcb4p as measured by kinase
activity in subcellular fractions (Fig. 1B, compare values for
wild-type RCD224 with lcb4v lcb5v RCD220 cells carrying
pLCB4-27, 6 h induction). After 24 h of galactose induction
the distribution of Lcb4p-3HA activity changed so that less
activity was in the S100 soluble fraction and more was in the
P13, plasma membrane (PM) fraction (Fig. 1B).
3.2. Lcb4p localizes to Golgi and endosomes
By indirect immuno£uorescence microscopy Lcb4p-3HA
was observed both as punctate spots and as di¡use patches
in the interior of cells (Fig. 2A), suggesting localization to
Golgi or endosomes. To determine which compartment con-
tained Lcb4p-3HA, cells were stained for Sec7p, a late Golgi
marker (trans-Golgi network [14]), for Tlg1p, found in both
Fig. 1. Production of HA-tagged Lcb4p in yeast cells. A: Lcb4p
was quanti¢ed by immunoblotting with Lcb4p antibodies. Extracts
analyzed in lanes 1^3 were prepared from cells grown to an A600 nm
of 0.6^0.7 in YPD medium (lanes 1 and 2) or SD-Ura (lane 3). For
the samples shown in lanes 4^6 the cells were grown overnight in
SD-Ura to an A600 nm of 0.4, resuspended in S-Ura containing 2%
galactose and extracts were prepared after 0, 6 or 24 h incubation.
B: LCB kinase speci¢c activity values represent the average of tripli-
cate assaysTS.D. Untransformed RCD224 and RCD220 cells were
grown in YPD to an A600 nm of 1. RCD220/pLCB4-27 cells were
grown in SD-Ura medium to an A600 nm of 1, washed three times
with water, resuspended in S-Ura with 2% galactose as the carbon
source and grown for 0, 6 or 24 h before cell fractionation and en-
zyme assay.
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Golgi and early endosomes [12], and for Pep12, found in late
endosomes [15,16]. Lcb4p-3HA primarily co-localized with
Sec7p (Fig. 2A), indicating localization in the Golgi and to
a lesser extent with Tlg1p, indicating co-localization in the
Golgi and possibly also in early endosomes. Some co-local-
ization with Pep12p in late endosomes was also seen.
As indicated above, overproduced Lcb4p-3HA tended to
localize in the P13 fraction (Fig. 1B, 24 h galactose induction),
suggesting binding to the PM. This ¢nding was veri¢ed by
indirect immuno£uorescence microscopy where a fraction of
the protein localized to the outer edge of cells where Pma1p,
the PM Hþ-ATPase, localized (Fig. 2B).
The subcellular location of Lcb4p-3HA was also analyzed
by equilibrium centrifugation in a sucrose density gradient.
The highest level of endogenous Lcb4p in wild-type cells
(RCD224) appeared in fractions that contained the late Golgi
marker Sec7p and the late endosomal marker Pep12p (frac-
tions 7 and 8, Fig. 3A). There was less Lcb4p in the early
endosomal fractions containing Tlg1p (fractions 11^14, Fig.
3A). In cells producing Lcb4p-3HA there was, in three sepa-
rate experiments, a consistent separation of fractions contain-
ing Sec7p and Pep12p (Fig. 3B), but Lcb4p-3HA was always
more abundant in the fraction containing Sec7p (fraction 5,
Fig. 3B). Again there was much less Lcb4p-3HA in the early
endosomal fractions containing Tlg1p (fractions 12^15, Fig.
3B). These data con¢rm the indirect immuno£uorescence mi-
croscopy data (Fig. 2A) and demonstrate that the majority of
Lcb4p-3HA is in the Golgi and endosomal compartments.
Many late Golgi proteins in yeast cycle between the late
Golgi and late endosomes or the prevacuolar compartment
(PVC) [17,18]. Cycling of Lcb4p between these two compart-
ments was examined by using vps27v cells, which are blocked
in transit of proteins from the PVC to the vacuole and the
Golgi. vps27v cells have an enlarged PVC usually located near
Fig. 2. Lcb4p-3HA localizes to the Golgi apparatus and to early and late endosomes. A: RCD220 (lcb4v lcb5v) cells transformed with pLCB4-
27 were grown as described in the legend to Fig. 1 and treated with galactose for 6 h. Samples were processed for immuno£uorescent microsco-
py by treating ¢rst with anti-HA antibody (Lcb4p) or with antobodies speci¢c for Sec7p, a Golgi marker, Tlg1p, an early endosomal marker,
or Pep12p, a late endosomal marker. Secondary antibodies were coupled to FITC, left panel, or to Cy3, center panels, and the £uorescent sig-
nals were merged to identify sites in which Lcb4p co-localized with the marker protein (yellow signals indicated by an arrow, right panels). B:
RCD220 (lcb4v lcb5v) cells transormed with pLCB4-27 were grown as described in the legend to Fig. 1 and treated with galactose for 24 h be-
fore examination by indirect immuno£uorescence microscopy as in panel A. Arrows indicate Lcb4p localization on the PM. A Normarski im-
age is shown at the left. C: The expression level of Lcb4p-3HA in RCD388/pLCB4-27 cells was compared to the level of endogenous Lcb4p in
wild-type RCD224 cells and in RCD220 (lcb4v lcb5v) and RCD388 control cells, which both lack Lcb4p. Untransformed cells were grown in
S medium containing 2% ra⁄nose and transformed cells were grown in the same medium lacking uracil. Samples immunoblotted with anti-
Lcb4p show that the level of Lcb4p-3HA in RCD388/pLCB4-27 cells was induced about two-fold above the wild-type level after 2 h of galac-
tose induction. D: Indirect immuno£uorescence microscopy of RCD388/pLCB4-27 cells grown as in panel C and stained ¢rst with anti-HA
antibody (Lcb4p-3HA) and with anti-Pep12p antibody. Secondary antibodies are the same as in panel A. Arrows indicate overlap of the £uo-
rescent signals and represent the enlarged PVC found in vps27v cells.
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the vacuole [19,20]. In vps27v cells Lcb4p-3HA was observed
in PVC-like structures and co-localized with Pep12p, a marker
for late endosomes/PVC [20] (Fig. 2D). These data support
the idea that Lcb4p cycles between the late Golgi and late
endosomes/PVC in a manner similar to other late Golgi pro-
teins (reviewed in [21]).
3.3. Overproduced Lcb4p accumulates on the PM
The data shown in Figs. 1B and 2B suggest that a portion
of overproduced Lcb4p-3HA binds to the PM. To verify this
¢nding and to determine if the protein is enzymatically active,
Lcb4p-3HA overproduced in wild-type RCD224 cells was sep-
arated into a highly puri¢ed PM fraction, a fraction contain-
ing other membranes (P150) and a soluble fraction (S150).
The purity of fractions was assessed by immunoblotting for
marker proteins (Fig. 4, legend). Pma1p was highly enriched
in the PM fraction which contained none or very low levels of
the other proteins, indicating that the PMs were very pure
(Fig. 4A). At time 0 about 60% of endogenous Lcb4p was
in the P150 fraction with the rest in the S150 fraction and
none in the PM fraction. After 24 h of galactose induction
Lcb4p-3HA was overproduced 15-fold and 48% was in the
PM fraction, 29% was in the P150 fraction and the rest was
in the S150 fraction. These data support the indirect immu-
no£uorescence data (Fig. 2B) and demonstrate that about half
of Lcb4p-3HA binds to the PM when the protein is overpro-
duced 15-fold.
Fractions were also assayed for LCB kinase activity (Fig.
4B). At time zero 81% of the enzyme activity was in the P150
fraction of RCD224/pLCB4-27 cells and about 2% was in the
PM fraction. After 24 h of galactose induction two-thirds of
the activity was in the S150 fraction and only about 1% was in
the PM fraction. Because 48% of overproduced Lcb4p-3HA
protein (24 h sample) binds to the PM but only has a speci¢c
activity three-fold above that in wild-type RCD224 cells of
RCD224/pLCB4-27 cells at the 0 h time point, we conclude
that Lcb4p bound to the PM is much less enzymatically active
than is the enzyme in the P150 and S150 fractions.
3.4. Lcb4p faces the cytoplasm and is tightly bound to
membranes
Sensitivity to protease digestion was used to determine if
Fig. 3. Localization of Lcb4p by density gradient centrifugation. A:
Density gradient pro¢le of the P100 fraction of wild-type RCD224
cells. B: RCD220 cells transformed with pLCB4-27 and induced for
6 h by growth in the presence of galactose. Gradient fractions were
analyzed for marker proteins by Western blotting using anti-Sec7p
(Golgi), anti-Pep12p (late endosomes) and anti-Tlg1p (early endo-
somes) antibodies. Proteins in each fraction are expressed as percen-
tages of the total £uorescent signal obtained by immunoblotting.
Lcb4p (panel A) and Lcb4p-3HA (panel B) enzyme activity is ex-
pressed as a percentage of the total activity on the gradient.
Fig. 4. Overproduced Lcb4p localizes to the PM and has reduced
enzyme activity. A: Untransformed RCD224 cells were grown in
YPD to an A600 nm of 1 and fractionated. Cells transformed with
pLCB4-27 were grown in SD-Ura medium to an A600 nm of 1,
washed three times with water, resuspended in S-Ura medium with
2% galactose as the carbon source and fractionated after 0 and 24 h
of growth at 30‡C. The PM, P150 and S150 fractions (25 Wg) were
immunoblotted for Lcb4p-3HA, Pma1p (plasma membrane), Vph1p
(vacuole), 3-phospho-glycerate kinase (cytosol), Dpm1p (ER) and a
mitochondrial porin. The percent distribution indicated below each
lane represents the pixels in each band divided by the total pixels in
the PM, P150 and S150 bands for each time point. B: Speci¢c ac-
tivity values for untransformed wild-type RCD224 are the average
of three experiments. Values for RCD224/pLCB4-27 cells are for
one experiment assayed in triplicate. The percent distribution repre-
sents the total Lcb4p kinase activity in each fraction.
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Lcb3p-3HA is in the lumen or on the cytoplasmic face of
Golgi and endosomes. Membranes were treated or not treated
with trypsin in the presence or absence of Triton X-100 and
immunoblotted. Lcb4p-3HA was sensitive to trypsin digestion
even in the absence of Triton (Fig. 5A), in contrast to the
lumenal marker protein GFP-HDEL (green £uorescence pro-
tein with an HDEL peptide sequence attached to its C-termi-
nus), which was only sensitive to protease digestion in the
presence of Triton. Sensitivity to protease digestion in the
absence of detergent indicates that Lcb4p is bound to the
cytoplasmic face of membranes.
To determine the nature of the association of Lcb4p-3HA
with membranes, the P100 membrane fraction was treated
with low pH (0.5 M potassium acetate, pH 4.5), with high
salt (1 M NaCl) or with high pH (0.1 M sodium carbonate,
pH 11), which release proteins that are weakly bound to mem-
branes by ionic interactions, or with the chaotropic agent
urea, which disrupts protein^protein interactions [22]. None
of these treatments released Lcb4p-3HA from membranes
(Fig. 5B), indicating that binding is quite strong. Treatment
with 0.5 or 1.0% Triton X-100, which disrupts membranes,
partially solubilized Lcb4p-3HA (Fig. 5C). Sonication of the
samples to release protein trapped in multi-layered membrane
vesicles, solubilized more but still not all of the protein (Fig.
5C). These results suggest that Lcb3p-3HA binds to a mem-
brane protein which may be part of a large, detergent-resis-
tant and sedimentable complex.
4. Discussion
A major ¢nding of this work is that Lcb4p is found pri-
marily in the Golgi, probably the trans-Golgi network, and in
late endosomes/PVC (Figs. 2 and 3). Data (Fig. 2D) also show
that Lcb4p cycles back and forth between the trans-Golgi
network and late endosomes/PVC, like many other mem-
brane-bound proteins (reviewed in [21]).
Until now there has been no indication of where DHS-P
and PHS-P are synthesized in S. cerevisiae cells. Therefore, a
key implication of our data is that they are made in the Golgi
and in late endosomes/PVC. For synthesis to occur in these
organelles some fraction of de novo synthesized DHS and
PHS must escape acylation by the ceramide synthases in the
ER and transit to the Golgi to be phosphorylated. Alterna-
tively, breakdown of ceramide of complex sphingolipids could
provide DHS or PHS, but there is no indication of such turn-
over.
Localization of Lcb4p to Golgi and late endosomes/PVC is
unexpected because the biosynthetic enzymes for making
DHS and PHS are located in the ER as are the Lcb3p and
Ysr3p phosphatases and the Dpl1p lyase that degrade DHS-P
and PHS-P. Because of this separation of biosynthetic and
degradative pathways, DHS-P and PHS-P would need to be
transported from the Golgi to the ER for breakdown to oc-
cur. It is known that exogenous LCBs must ¢rst be phosphor-
ylated and then dephosphorylated in order for S. cerevisiae
cells to e⁄ciently incorporate them into ceramides [23^26].
Our data imply that phosphorylation of the majority of exog-
enous LCBs is catalyzed by Lcb4p on the Golgi and late
endosomes/PVC followed by transit to the ER where they
are dephosphorylated before incorporation into ceramides.
A general function for Lcb4p is to regulate LCBs and re-
duce their concentration back to the basal level following a
heat-induced increase [27]. Our Lcb4p localization data extend
this idea and argue that the rise in LCBs, which most likely
occurs by de novo synthesis in the ER, would be followed by
transport to the Golgi where their concentration would be
reduced by phosphorylation. This prediction is supported by
the rate of increase in the concentration of LCBs, which oc-
curs 5^10 min prior to the increase in LCBPs [27]. If, as we
hypothesize, LCBPs are made in the Golgi and late endo-
somes/PVC then they may function to regulate processes per-
formed in these compartments including protein and lipid
modi¢cation, processing, sorting, transport and degradation.
Our analysis of the buoyant density of endosomes and Golgi
suggest that Lcb4p or Lcb5p and LCBPs have a physiological
function in one of these organelles. In RCD224 wild-type cells
the Golgi and late endosomal marker proteins (Sec7p and
Pep12p, respectively) coincided, whereas in RCD220 (lcb4v
lcb5v) cells the Sec7p Golgi marker was shifted to a slightly
lower buoyant density (Fig. 4). Further work will be needed
to understand the physical basis for this change in buoyant
density.
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